IP Verse

Lozenge For Treating A Sore Throat, Hoarseness, And Associated Dry Cough And For Treating Inflammatory Diseases Of The Oral Cavity And Of The Pharynx

EP2981275

BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Application Number
EP14715256A
Filing Date
Mar 31, 2014
Status
Granted And Under Opposition
Dec 7, 2018
Grant Date
Jan 9, 2019
External Links
Slate, Register

Biblio Summary

The patent EP2981275B1 was granted on Jan 9, 2019 by Boehringer Ingelheim International Gmbh The patent is currently Granted And Under Opposition.

Oppositions Filed by other Companies on the Patent

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

STREHLKE, INGO KURTOct 9, 2019WITHDRAWN

More Opposed Patents of Boehringer Ingelheim International Gmbh

The table below shows the patents of Boehringer Ingelheim International Gmbh that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2395968Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientJan 17, 202418
EP2313087Pharmaceutical Dosage Form For Immediate Release Of An Indolinone DerivativeNov 22, 20233
EP3110449Medical Use Of A Dpp-4 InhibitorJun 28, 20235

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents